Mind Medicine (MindMed) Inc. financial data

Symbol
MNMD on Nasdaq
Location
One World Trade Center, Suite 8500, New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Jul 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 706 % +65.5%
Debt-to-equity 27.5 % -33.8%
Return On Equity -50.2 % +29.6%
Return On Assets -39.4 % +21.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 76.1M shares +5.47%
Common Stock, Shares, Outstanding 75.8M shares +5.17%
Entity Public Float 515M USD +268%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 85.3M shares +18.7%
Weighted Average Number of Shares Outstanding, Diluted 85.3M shares +13.3%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 92.1M USD +80.3%
General and Administrative Expense 38.2M USD -3%
Operating Income (Loss) -130M USD -44%
Net Income (Loss) Attributable to Parent -115M USD -12.2%
Earnings Per Share, Basic -1 USD/shares +51.6%
Earnings Per Share, Diluted 0 USD/shares +59.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 33.4M USD -86.3%
Assets, Current 189M USD -23.6%
Operating Lease, Right-of-Use Asset 600K USD
Goodwill 19.9M USD 0%
Other Assets, Noncurrent 1.17M USD +120%
Assets 265M USD -1.14%
Accounts Payable, Current 4.22M USD +43.6%
Accrued Liabilities, Current 14.8M USD +79.8%
Liabilities, Current 38M USD -9.3%
Other Liabilities, Noncurrent 543K USD
Liabilities 79.7M USD +20.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 807K USD -3.12%
Retained Earnings (Accumulated Deficit) -465M USD -32.7%
Stockholders' Equity Attributable to Parent 185M USD -8.24%
Liabilities and Equity 265M USD -1.14%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.4M USD -77.2%
Net Cash Provided by (Used in) Financing Activities 1M USD -99.4%
Net Cash Provided by (Used in) Investing Activities -162M USD
Common Stock, Shares, Issued 75.8M shares +5.17%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -191M USD -225%
Interest Paid, Excluding Capitalized Interest, Operating Activities 602K USD +38.7%
Deferred Tax Assets, Valuation Allowance 69.9M USD +37%
Operating Lease, Liability 600K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -115M USD -12.8%
Deferred Tax Assets, Operating Loss Carryforwards 42.5M USD +34.6%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 900K USD
Amortization of Intangible Assets 0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance 0 USD -100%
Share-based Payment Arrangement, Expense 16.5M USD -1.42%
Interest Expense 4.32M USD +159%